doi:10.48130/mpb-0026-0006

[1]

Swogger MT, Torrice T, Grundmann O. 2026. Chapter 3 - Kratom use: a review of patterns and motivations. In Kratom: History, Science and Therapeutic Potential, eds. Henningfield JE, Beyer CE, Raffa RB. Cambridge, USA: Academic Press. pp. 21–34 doi: 10.1016/B978-0-443-27412-1.00003-1

[2]

Patel AK, Lodha D, Shekhawat NS. 2020. An improved micropropagation protocol for the ex-situ conservation of Mitragyna parvifolia (Roxb.) Korth. (Rubiaceae): an endangered tree of pharmaceutical importance. In Vitro Cellular & Developmental Biology - Plant 56:817−826

doi: 10.1007/s11627-020-10089-6

[3]

Ahmad I, Prabowo WC, Arifuddin M, Fadraersada J, Indriyanti N, et al. 2022. Mitragyna species as pharmacological agents: from abuse to promising pharmaceutical products. Life 12:193

doi: 10.3390/life12020193

[4]

Wahbeh A, Al-Ramahi M, El-Gayar O, Nasralah T, Elnoshokaty A. 2024. Health benefits and adverse effects of kratom: a social media text-mining approach. Informatics 11:63

doi: 10.3390/informatics11030063

[5]

Begum T, Arzmi MH, Khatib A, Uddin ABMH, Aisyah Abdullah M, et al. 2025. A review on Mitragyna speciosa (Rubiaceae) as a prominent medicinal plant based on ethnobotany, phytochemistry and pharmacological activities. Natural Product Research 39:1636−1652

doi: 10.1080/14786419.2024.2371564

[6]

Bunman S, Wannapaschaiyong P. 2025. Understanding the effects and clinical potential of kratom (Mitragyna speciosa): a narrative review. The Bangkok Medical Journal 21:73−77

doi: 10.31524/bkkmedj.2025.13.002

[7]

Veltri C, Grundmann O. 2019. Current perspectives on the impact of Kratom use. Substance Abuse and Rehabilitation 10:23−31

doi: 10.2147/SAR.S164261

[8]

Thepthien BO, Jayasvasti I, Ham E. 2024. The prevalence of kratom use and association with co-occurring substance use among adolescents: a 2022 Bangkok behavioral surveillance survey, Thailand. Journal of Ethnicity in Substance Abuse 23:1−15

doi: 10.1080/15332640.2024.2367233

[9]

Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, et al. 2017. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Human Psychopharmacology: Clinical and Experimental 32:e2582

doi: 10.1002/hup.2582

[10]

Ya K, Tangamornsuksan W, Scholfield CN, Methaneethorn J, Lohitnavy M. 2019. Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): a systematic review. Asian Journal of Psychiatry 43:73−82

doi: 10.1016/j.ajp.2019.05.016

[11]

Leksungnoen N, Andriyas T, Ngernsaengsaruay C, Uthairatsamee S, Racharak P, et al. 2022. Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand. Frontiers in Plant Science 13:1028547

doi: 10.3389/fpls.2022.1028547

[12]

Sengnon N, Vonghirundecha P, Chaichan W, Juengwatanatrakul T, Onthong J, et al. 2023. Seasonal and geographic variation in alkaloid content of kratom (Mitragyna speciosa [Korth.] Havil.) from Thailand. Plants 12:949

doi: 10.3390/plants12040949

[13]

Begum T, Arzmi MH, Helal Uddin ABM, Khatib A, Abbas SA, et al. 2024. Mitragyna speciosa Korth toxicity: experimental findings and future prospects. Journal of Taibah University Medical Sciences 19:1143−1156

doi: 10.1016/j.jtumed.2024.12.002

[14]

Grundmann O, Hendrickson RG, Greenberg MI. 2023. Kratom: history, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month 69:101442

doi: 10.1016/j.disamonth.2022.101442

[15]

Singh D, Narayanan S, Vicknasingam B. 2016. Traditional and non-traditional uses of Mitragynine (Kratom): a survey of the literature. Brain Research Bulletin 126:41−46

doi: 10.1016/j.brainresbull.2016.05.004

[16]

Brown PN, Lund JA, Murch SJ. 2017. A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna Korth: implications for products sold as kratom. Journal of Ethnopharmacology, 202:302−325

doi: 10.1016/j.jep.2017.03.020

[17]

Ridsdale CE. 1978. A revision of Mitragyna and Uncaria (Rubiaceae). Blumea: Biodiversity, Evolution and Biogeography of Plants 24:43−100

[18]

Chaowiset W, Sooksmarn S, Muangthip K. 2024. Morphological diversity of Kratom (Mitragyna speciosa [Korth.] Havil.) at population level in Southern Thailand. Journal of Science and Technology Mahasarakham University 43:308−319

[19]

Zhang M, Sharma A, León F, Avery B, Kjelgren R, et al. 2020. Effects of nutrient fertility on growth and alkaloidal content in Mitragyna speciosa (kratom). Frontiers in Plant Science 11:597696

doi: 10.3389/fpls.2020.597696

[20]

Pandey R, Singh SC, Gupta MM. 2006. Heteroyohimbinoid type oxindole alkaloids from Mitragyna parvifolia. Phytochemistry 67:2164−2169

doi: 10.1016/j.phytochem.2006.06.017

[21]

Suwanlert S. 1975. A study of kratom eaters in Thailand. Bulletin on Narcotics 27:21−27

[22]

Hassan Z, Muzaimi M, Navaratnam V, Yusoff NHM, Suhaimi FW, et al. 2013. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews 37:138−151

doi: 10.1016/j.neubiorev.2012.11.012

[23]

Charoenratana S, Anukul C, Aramrattana A. 2021. Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand. International Journal of Drug Policy 95:103197

doi: 10.1016/j.drugpo.2021.103197

[24]

Donroe JH, Fiellin DA. 2022. A case of kratom use: implications for managing addiction and addressing comorbidity in overdose survivors, and for the education of clinicians who are not addiction specialists. Journal of Addiction Medicine 16:138−140

doi: 10.1097/ADM.0000000000000872

[25]

Saingam D, Assanangkornchai S, Geater AF, Balthip Q. 2013. Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: a qualitative study. International Journal of Drug Policy 24:351−358

doi: 10.1016/j.drugpo.2012.09.004

[26]

Chang-Chien GC, Odonkor CA, Amorapanth P. 2017. Is kratom the new ‘legal high’ on the block? The case of an emerging opioid receptor agonist with substance abuse potential. Pain Physician 20:E195−E198

doi: 10.36076/ppj.2017.1.e195

[27]

Vicknasingam B, Narayanan S, Beng GT, Mansor SM. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy 21:283−288

doi: 10.1016/j.drugpo.2009.12.003

[28]

Thai Drug Watch. 2022. กระท่อม สมุนไพรที่ถูกห้ามใช้เกือบศตวรรษ. Flokdoctor. pp. 14−19 https://www.thaidrugwatch.org/download/2565-10_folkdoctor-510_kratom.pdf

[29]

Boonmak J. 2020. Kratom: herbal medicine and according to southern local knowledge under legal restrictions and misuse in young adult. Journal of Health Policy, Law and Administration 6:211−226

[30]

Frost EAM. 2019. Kratom: a cure for chronic pain or a deadly herb? Topics in Pain Management 35:1−6

doi: 10.1097/01.bmsas.0000614836.47920.c0

[31]

Ramanathan S, McCurdy CR. 2020. Kratom (Mitragyna speciosa): worldwide issues. Current Opinion in Psychiatry 33:312−318

doi: 10.1097/YCO.0000000000000621

[32]

Talek M, Cottler LB, Wichaidit W, Assanangkornchai S. 2021. Patterns of kratom use among male drug users in the deep south of Thailand. Thai Journal of Public Health 51:16−24

[33]

Adkins JE, Boyer EW, McCurdy CR. 2011. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry 11:1165−1175

doi: 10.2174/156802611795371305

[34]

Jadhav U, Ghumare P, Jirekar D. 2022. A review of Mitragyna parvifolia (Roxb.) Korth. – an important medicinal plant. Journal of Science & Technology 7:53−59

[35]

Panwar J, Tarafdar JC. 2006. Arbuscular mycorrhizal fungal dynamics under Mitragyna parvifolia (Roxb.) Korth. in Thar Desert. Applied Soil Ecology 34:200−208

doi: 10.1016/j.apsoil.2006.02.001

[36]

Sharma A, McCurdy CR. 2021. Assessing the therapeutic potential and toxicity of Mitragyna speciosa in opioid use disorder. Expert Opinion on Drug Metabolism & Toxicology 17:255−257

doi: 10.1080/17425255.2021.1853706

[37]

Kamble SH, Sharma A, King TI, Berthold EC, León F, et al. 2020. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids. Toxicology Letters 319:148−154

doi: 10.1016/j.toxlet.2019.11.005

[38]

Harizal SN, Mansor SM, Hasnan J, Tharakan JKJ, Abdullah J. 2010. Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in Rodent. Journal of Ethnopharmacology 131:404−409

doi: 10.1016/j.jep.2010.07.013

[39]

Jansen KLR, Prast CJ. 1988. Ethnopharmacology of kratom and the Mitragyna alkaloids. Journal of Ethnopharmacology 23:115−119

doi: 10.1016/0378-8741(88)90121-3

[40]

Takayama H. 2004. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chemical and Pharmaceutical Bulletin 52:916−928

doi: 10.1248/cpb.52.916

[41]

Hassan Z, Bosch OG, Singh D, Narayanan S, Kasinather BV, et al. 2017. Novel psychoactive substances—recent progress on neuropharmacological mechanisms of action for selected drugs. Frontiers in Psychiatry 8:152

doi: 10.3389/fpsyt.2017.00152

[42]

Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, et al. 2002. Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. Journal of Medicinal Chemistry 45:1949−1956

doi: 10.1021/jm010576e

[43]

Matsumoto K, Horie S, Takayama H, Ishikawa H, Aimi N, et al. 2005. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Sciences 78:2−7

doi: 10.1016/j.lfs.2004.10.086

[44]

Rashid MH, Williams MJ, Garcia Guerra A, Itharat A, Loebenberg R, et al. 2026. Therapeutic potential, predictive pharmaceutical modeling, and metabolic interactions of the oxindole kratom alkaloids. Journal of Phytomedicine 1:2

doi: 10.3390/jphytomed1010002

[45]

Meireles V, Rosado T, Barroso M, Soares S, Gonçalves J, et al. 2019. Mitragyna speciosa: clinical, toxicological aspects and analysis in biological and non-biological samples. Medicines 6:35

doi: 10.3390/medicines6010035

[46]

Idayu NF, Hidayat MT, Moklas MAM, Sharida F, Nurul Raudzah AR, et al. 2011. Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine 18:402−407

doi: 10.1016/j.phymed.2010.08.011

[47]

Shaik Mossadeq WM, Sulaiman MR, Tengku Mohamad TA, Chiong HS, Zakaria ZA, et al. 2009. Anti-inflammatory and antinociceptive effects of Mitragyna speciosa Korth methanolic extract. Medical Principles and Practice 18:378−384

doi: 10.1159/000226292

[48]

Rahmawati SI, Indriani DW, Ningsih FN, Hardhiyuna M, Firdayani F, et al. 2024. Dual anti-inflammatory activities of COX-2/5-LOX driven by kratom alkaloid extracts in lipopolysaccharide-induced RAW 264.7 cells. Scientific Reports 14:28993

doi: 10.1038/s41598-024-79229-x

[49]

Utar Z, Majid MIA, Adenan MI, Jamil MFA, Lan TM. 2011. Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E₂ production induced by lipopolysaccharide in RAW264.7 macrophage cells. Journal of Ethnopharmacology 136:75−82

doi: 10.1016/j.jep.2011.04.011

[50]

Hossain R, Sultana A, Nuinoon M, Noonong K, Tangpong J, et al. 2023. A critical review of the neuropharmacological effects of kratom: an insight from the functional array of identified natural compounds. Molecules 28:7372

doi: 10.3390/molecules28217372

[51]

Chae HS, Park HJ, Hwang HR, Kwon A, Lim WH, et al. 2011. The effect of antioxidants on the production of pro-inflammatory cytokines and orthodontic tooth movement. Molecules and Cells 32:189−196

doi: 10.1007/s10059-011-0071-1

[52]

Parthasarathy S, Bin Azizi J, Ramanathan S, Ismail S, Sasidharan S, et al. 2009. Evaluation of antioxidant and antibacterial activities of aqueous, methanolic and alkaloid extracts from Mitragyna speciosa (Rubiaceae family) leaves. Molecules 14:3964−3974

doi: 10.3390/molecules14103964

[53]

Matsumoto K, Hatori Y, Murayama T, Tashima K, Wongseripipatana S, et al. 2006. Involvement of $\mu $-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. European Journal of Pharmacology 549:63−70

doi: 10.1016/j.ejphar.2006.08.013

[54]

Tsuchiya S, Miyashita S, Yamamoto M, Horie S, Sakai SI, et al. 2002. Effect of mitragynine, derived from Thai folk medicine, on gastric acid secretion through opioid receptor in anesthetized rats. European Journal of Pharmacology 443:185−188

doi: 10.1016/S0014-2999(02)01588-1

[55]

Sabran, Sihaloho NTP. 2023. Empowering kratom farmers in strengthening functions of family institutions in Hulu Kapuas District. Ilomata International Journal of Social Science 4:727−735

doi: 10.52728/ijss.v4i4.960

[56]

Tobing ML, Siregar MA, Aspan H. 2024. Legal implications of drug use in traditional medicine based on a health law perspective. International Journal of Synergy in Law, Criminal, and Justice 1:206−213

[57]

Adjétey TAK, Djè MK, Vangah-Manda M, Adoubryn KD, Koné LP, et al. 2007. Antimalarial activity of Mitragyna ciliata (Aubrev and Pellegr) (Rubiaceae): preliminary study. South African Journal of Botany 73:226−229

doi: 10.1016/j.sajb.2007.01.003

[58]

Azas N, Laurencin N, Delmas F, Di Giorgio C, Gasquet M, et al. 2002. Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali. Parasitology Research 88:165−171

doi: 10.1007/s004360100454

[59]

Toklo PM, Yayi-Ladekan E, Sakirigui A, Assogba FM, Alowanou GG, et al. 2020. Phytochemistry and pharmacological review of Mitragyna inermis (Willd.) Kuntze (Rubiaceae). Journal of Pharmacognosy and Phytochemistry 9:22−30

[60]

Yemié AA, Boni AR, Beourou S, N’Guessan JD. 2022. Evaluation of in vitro antiplasmodial activity and chromatographic analysis for quinine and codeine quantification from the total alkaloids extract of Mitragyna ciliata. Pharmacognosy Research 14:135−139

doi: 10.5530/pres.14.2.19

[61]

Thongsuntud N. 2021. Effect of Mitragyna speciosa (Korth) Havil. extract in Plasmodium yoelii (Py) infected mice. Thesis. Silpakorn University, Thailand. 91 pp. http://ithesis-ir.su.ac.th/dspace/bitstream/123456789/3894/1/60312303.pdf

[62]

Darakai V, Punsawad C, Jitonnom J, Nisoa M, Rattanakit P. 2024. Microwave-assisted ultrafine silver nanoparticle synthesis using Mitragyna speciosa for antimalarial applications. Green Processing and Synthesis 13:20230257

doi: 10.1515/gps-2023-0257

[63]

Biswas PC, Jakhmola V, Samanta A, Kapri A, Ansori ANM, et al. 2025. Integrating nanoparticles and herbal extracts with platinum-based chemotherapy for enhanced efficacy and reduced toxicity (a review). Pharmaceutical Chemistry Journal 59:159−167

doi: 10.1007/s11094-025-03375-3

[64]

Traore-Keita F, Gasquet M, Di Giorgio C, Ollivier E, Delmas F, et al. 2000. Antimalarial activity of four plants used in traditional medicine in Mali. Phytotherapy Research 14:45−47

doi: 10.1002/(sici)1099-1573(200002)14:1<45::aid-ptr544>3.0.co;2-c

[65]

Kayode OT, Lele CK, Kayode AAA. 2020. Trypanosomiasis: recent advances in strategies for control. Global Journal of Infectious Diseases and Clinical Research 6:37−41

doi: 10.17352/2455-5363.000033

[66]

Plaatjie M, Onyiche T, Legoabe L, Ramatla T, Nyembe N, et al. 2023. Medicinal plants as potential therapeutic agents for trypanosomosis: a systematic review. Advances in Traditional Medicine 23:1011−1033

doi: 10.1007/s13596-022-00662-2

[67]

Wamwiri FN, Changasi RE. 2016. Tsetse flies (Glossina) as vectors of human African trypanosomiasis: a review. BioMed Research International 2016:6201350

doi: 10.1155/2016/6201350

[68]

Dutta Choudhury K, Dutta Choudhury M. 2011. Antifungal and antiprotozoal activity of some members of Rubiaceae-a review. NBU Journal of Plant Sciences 5:8−14

[69]

Tullius Scotti M, Scotti L, Ishiki H, Fávaro Ribeiro F, Marques Duarte da Cruz R, et al. 2016. Natural products as a source for antileishmanial and antitrypanosomal agents. Combinatorial Chemistry & High Throughput Screening 19:537−553

doi: 10.2174/1386207319666160506123921

[70]

Ogbunugafor HA. 2009. The biochemical studies of the trypanocidal activity of Mitragyna ciliata Aubrev and Pellegr (Rubiciaceae). Phd Thesis and Dissertation, University of Lagos School of Postgraduate Studies, Nigeria. 130 pp. https://ir.unilag.edu.ng/handle/123456789/4362

[71]

Alemayehu B, Alemayehu M. 2017. Leishmaniasis: a review on parasite, vector and reservoir host. Health Science Journal 11:1−6

doi: 10.21767/1791-809x.1000519

[72]

Ohashi M, Amoa-Bosompem M, Kwofie KD, Agyapong J, Adegle R, et al. 2018. In vitro antiprotozoan activity and mechanisms of action of selected Ghanaian medicinal plants against trypanosoma, leishmania, and plasmodium parasites. Phytotherapy Research 32:1617−1630

doi: 10.1002/ptr.6093

[73]

Hassan AA, Khalid HE, Abdalla AH, Mukhtar MM, Osman WJ, et al. 2022. Antileishmanial activities of medicinal herbs and phytochemicals in vitro and in vivo: an update for the years 2015 to 2021. Molecules 27:7579

doi: 10.3390/molecules27217579

[74]

Perez M, Espadinha M, MM Santos M. 2015. Indolo[2,3-a]quinolizidines and derivatives: bioactivity and asymmetric synthesis. Current Pharmaceutical Design 21:5518−5546

doi: 10.2174/1381612821666151002112934

[75]

Singh S, Monga Y, Sharma S, Gupta A. 2023. A review on indole[2,3-a]quinolizidine: the synthetic approaches to the development of bioactive indolo[2,3-a]quinolizidine scaffolds. Heterocycles 106:1617

doi: 10.3987/rev-23-1008

[76]

Bilal H, Akram W, Din S, Khan IA, Hassan SA, et al. 2012. Larvicidal activity of selected plant extracts against Aedes albopictus Skuse (Diptera: Culicidae). African Entomology 20:8−12

doi: 10.4001/003.020.0102

[77]

Abd Jalil A, Zaki ZM, Hasan MKN, Jin CB, Ramli MDC, et al. 2021. Screening of selected local plant extracts for their repellent activity against Aedes albopictusmosquitoes. Asian Journal of Pharmacognosy 4:30−37

[78]

Sparg SG, van Staden J, Jäger AK. 2000. Efficiency of traditionally used South African plants against schistosomiasis. Journal of Ethnopharmacology 73:209−214

doi: 10.1016/S0378-8741(00)00310-X

[79]

Chomba C, Mutale S. 2014. Factors characterising high prevalence rates of urinary schistosomiasis in Mufumbwe district, north western province of Zambia. Global Journal of Biology, Agriculture and Health Sciences 3:86−95

[80]

Abajue MC, Wogu MN. 2023. Medicinal plants in the tropics used in the treatment and management of parasitic diseases transmitted by mosquitoes: administration, challenges, and strategic options for management. In Herbal Medicine Phytochemistry, eds. Izah SC, Ogwu MC, Akram M. Cham: Springer. pp. 1−34 doi: 10.1007/978-3-031-21973-3_61-1

[81]

Jebaseelan J, Sadiq SB, Ravikumar AP, Annaraj J, Balakrishnan AS. 2024. Mitragyna parvifolia as apotential therapeutic agent for lymphatic filariasis. Journal of Parasitic Diseases 48:474−484

doi: 10.1007/s12639-024-01683-1